Predictors of good clinical response (BASDAI 50 or ASAS partial remission) in 1,250 patients treated with adalimumab (humira (R)) for active ankylosing spondylitis (AS) - Rudwaleit, M; Claudepierre, P; Wordsworth, P; Loza, E; Wong, R; Kron, M; Kary, S; Kupper, H (CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008)